Search results
Dec 7, 2021 · MOG antibody disease (MOGAD) is a neurological, immune-mediated disorder in which there is inflammation in the optic nerve, spinal cord and/or brain. Myelin oligodendrocyte glycoprotein (MOG) is a protein that is located on the surface of myelin sheaths in the central nervous system.
What is myelin oligodendrocyte glycoprotein antibody disease? Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) are a spectrum of idiopathic, inflammatory, demyelinating diseases affecting the central nervous system (CNS).
MOG antibody disease (MOGAD) or MOG antibody-associated encephalomyelitis (MOG-EM) is an inflammatory demyelinating disease of the central nervous system.
Sep 9, 2021 · Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a condition that causes inflammation in the nervous system. In MOGAD, antibodies attack a protein called myelin...
Mar 10, 2024 · Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an autoimmune condition where your immune system mistakenly attacks parts of your central nervous system. MOG is part of the protective cover that surrounds nerves in your brain, spinal cord and eyes (optic nerves).
- www.mayoclinic.org
- › …
- › Diseases & Conditions
Jan 3, 2024 · Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In MOGAD, the immune system attacks the fatty substance that protects nerve fibers in the optic nerves, brain and spinal cord.
Nov 22, 2023 · Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder of the central nervous system characterized by attacks of immune-mediated demyelination predominantly targeting the optic nerves, brain, and spinal cord. The disease has a predilection for children.
- www.ncbi.nlm.nih.gov
- › Journal List
- › Springer
Dec 19, 2018 · Therefore, MOG antibody disease (MOG-AD) is now recognised as a distinct nosological entity with specific management and therapeutic requirements. In this article, we review the clinical features, investigations and challenges of managing patients with MOG-AD.
- www.mayoclinic.org
- › …
- › Diseases & Conditions
Jan 3, 2024 · Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Symptoms & causes; Diagnosis & treatment; Doctors & departments; Care at Mayo Clinic
Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a neurological, immune-mediated demyelinating disorder of the central nervous system that causes inflammation and potential damage in the optic nerve, spinal cord, brain and/or brainstem.
